Suven Pharmaceuticals acquires majority stake in NJ Bio, strengthens US presence
Suven Pharmaceuticals Limited, a technology-focused contract development and manufacturing organisation (CDMO), has announced the acquisition of a controlling 56% stake in NJ Bio Inc., a ... Read More
Suven Pharmaceuticals reports 12% revenue growth for Q2 with strong outlook
Suven Pharmaceuticals Ltd. (BSE: 530239, NSE: SUVENPHARM), a technology-focused Contract Development and Manufacturing Organization (CDMO) headquartered in Hyderabad, announced a 12% year-over-year revenue growth for ... Read More
Suven Pharma partners with CSIR-IICT to manufacture Molnupiravir and 2-DG
Suven Pharmaceuticals (Suven Pharma), CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad and CSIR-National Institute of Interdisciplinary Science & Technology, Thiruvananthapuram have forged an agreement for ... Read More